Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.

Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.

Item
http://www.wikidata.org/entity/Q34203843
LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteinsOmega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present.Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic micePlasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolismRecognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor.Post-prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia.Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway.Hepatocyte-derived ApoE is more effective than non-hepatocyte-derived ApoE in remnant lipoprotein clearance.Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia.Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia.
P2860

Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.

Item
http://www.wikidata.org/entity/Q34203843
description
1991 nî lūn-bûn
@nan
1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@ast
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@en
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@nl
type
label
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@ast
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@en
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@nl
prefLabel
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@ast
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@en
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Use of an anti-low density lip ...... remnants in the mouse in vivo.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932